Gene Therapy Market industry development trends and strategic plan for positive Growth discuss in research report.The global gene therapy market is estimated to be over US$ 411.2 Mn in 2018. It is anticipated to grow at a double-digit CAGR of 33.1% from 2019 to 2030.
New York, NY -- (SBWIRE) -- 03/31/2020 -- As per research findings of Market Industry Reports (MIR), increasing number of product approvals & R&D activities, supportive government initiatives in the gene therapy arena are set to open new avenues for stakeholders.
Major Players Include:
The global gene therapy market is largely governed by prominent players such as Novartis AG, UniQure N.V., Regenxbio Inc., Sibiono GeneTech Co. Ltd., Amgen Inc., Voyager Therapeutics, Sarepta Therapeutics, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, and Orchard Therapeutics plc, among others.
Get Access to Sample Pages @ https://www.marketindustryreports.com/pdf/149
Growth opportunities in the global gene therapy market looks promising during the forecast period. Rising incidences of chronic diseases as well as genetic disorders globally, favorable initiatives from governments to support research & development of gene therapy products and technological advancements are some of the key factors driving the global gene therapy market.
Similarly, increased focus of players in this market for getting approvals for gene therapy products is anticipated to boost the gene therapy market significantly during the forecast period. For instance, in May 2019, AveXis, a U.S.-based company received FDA's approval for Zolgensma. Zolgensma is used for the treatment of a rare genetic disorder and Spinal Muscular Atrophy (SMA) in pediatric patients below the age of 2 years.
"Companies are striving to discover, develop, and deliver gene therapies for rare genetic disorders,"
From a regional perspective, Europe is expected to witness the highest CAGR in the coming years due to presence of several gene therapy products in the development stage. Whereas, North America accounts for the largest share in the gene therapy market. The large share of this region can be attributed to rising incidences of chronic diseases & genetic disorders such as cancer, hemophilia, Multiple Sclerosis (MS), and others.
For deep-rooted insights on this topic, Go for Interesting Discount @ https://www.marketindustryreports.com/discount/149
By Vector Type
Herpes simplex virus
Naked plasmid vector
By Gene Type
REASONS TO BUY THE REPORT:
Deep-rooted quantitative and qualitative insights at segment & sub-segment level
Global insights with country levels information
Comprehensive insights on market dynamics, and business environment
Insights on 'Key Strategies' followed by leading players of the market
Access to 'Latest Strategic Developments' registered by leading players of the market
Key Distributors List
Free addition of 'Company Profiles'
Clientele Base Assessment
Byy Full Report Now @ https://www.marketindustryreports.com/checkout/149
About Market Industry Reports
Market Industry Reports is a global leader in market measurement and advisory services. It is a 100% subsidiary of ExlTech. The firm has always been at the forefront of innovations to address worldwide industry trends and opportunities. We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates consumer study in more than 100 countries, providing a tactical approach to drive sustained business growth. We continue to pioneer state-of-the-art approach in research & analysis that will help you to overcome complexities and stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence, we unfold contingencies for our clients in the evolving world of technology, mega-trends, and industry convergence. We inspire our clients to empower and shape their businesses and to build world-class products.
2nd Floor, Manikchand Ikon,
B-Wing, Dhole Patil Road,
Sangamwadi, Pune 411 001
+1 347 767 5477 ( US )
+44 131 463 4161 ( UK )
+ 91 8956 767 535 ( IN